Aluminum: Clinical Trials

3 trials of Aluminum, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 recruiting, 1 terminated. 1 Not applicable, 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable1Completed 1
Phase 21Recruiting 1
Phase 31Terminated 1

Follow Aluminum: new trials by email Literature Review of Aluminum trials Research Report on Aluminum

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Age-descending Study to Evaluate the Safety and Immunogenicity of the Cholera Conjugate Vaccine in Adults and Children
OSP:rTTHc CCV 25 ㎍ with Aluminum phosphate, OSP:rTTHc CCV 25 ㎍ without Aluminum phosphate, Euvichol®-Plus - Cholera Vaccination
Phase 2RecruitingInternational Vaccine Institute3902026-01-132026-04-03
Detection of Aluminium-reactive T-lymphocytes in Patients With Vaccination Granulomas
Aluminum, Tetanus toxoid - Granuloma, Aluminum Allergy
Not applicableCompletedNational Allergy Research Center, Denmark162022-09-132023-11-14
Tepilta® Versus Oxetacaine, Antacids and Placebo
oxetacaine, aluminium and magnesium hydroxide, oxetacaine, magnesium and aluminium hydroxide - Radiation-induced Oesophagitis
Phase 3TerminatedMEDA Pharma GmbH & Co. KG402011-04-012022-02-07

Conditions studied

Dermatitis, Contact (1)  ·  Granuloma (1)  ·  Hypersensitivity (1)

Sponsors

International Vaccine Institute (1)  ·  MEDA Pharma GmbH & Co. KG (1)  ·  National Allergy Research Center, Denmark (1)

Countries

Austria (1)  ·  Denmark (1)  ·  Germany (1)  ·  Kenya (1)

Top investigators

Frank Bruns, Dr. med. (1)  ·  Julia Lynch, MD (1)  ·  Lars Blom, PhD (1)  ·  Ursula Petzold, PhD (1)

NIH funding

2009 (1)